
FDA sets new decision date for Ipsen’s FOP therapy
US agency sets 23rd August deadline for palovarotene review as Ipsen files more clinical data.
Newsletters and Deep Dive digital magazine
US agency sets 23rd August deadline for palovarotene review as Ipsen files more clinical data.
Industry groups are happy with news on R&D tax credits, funding for MHRA, and investment zones.
Danish drugmaker says it will reduce the price of its insulin products in the US by up to 75%.
Passionate, effective, and forward-thinking female leaders are critical to driving innovation.
Department of Veterans Affairs will cover the drug for veterans with early-stage Alzheimer's.
Editor's Picks
Newsletters and Deep Dive
digital magazine